Unnamed Brokerage Backs Domestic Pharma Over US Generics Plays Ahead of Q1 FY27

Sun Pharma, Cipla and Jubilant Pharmova flagged as preferred picks as pricing pressure and policy uncertainty cloud high-value US generics near-term; no price targets disclosed.

ndtv-profit-business · 7/8/2026, 5:31:30 AM · Ask about this →